Recent advances in technology have led to the development of newer and more sophisticated toxicity models in drug discovery. These models provide a more accurate representation of drug toxicity and are essential in the development of safer and more effective drugs. The use of micro physiological systems, 3D bioprinting, human induced pluripotent stem cell models, CRISPR/Cas9 gene editing, and machine learning algorithms offer a range of benefits that can revolutionize drug discovery, including greater accuracy, cost-effectiveness, time-saving, and a personalized approach. Incorporating these recent toxicity models into drug discovery can significantly improve the development of safer and more effective drugs.
source
